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Abstract
Recent evidence suggests that lifestyle factors influence the association between the Mela-
nocortin 4 receptor (MC4R) and Transcription Factor 7-Like 2 (TCF7L2) gene variants and
cardio-metabolic traits in several populations; however, the available research is limited
among the Asian Indian population. Hence, the present study examined whether the associ-
ation between the MC4R single nucleotide polymorphism (SNP) (rs17782313) and two
SNPs of the TCF7L2 gene (rs12255372 and rs7903146) and cardio-metabolic traits is modi-
fied by dietary factors and physical activity. This cross sectional study included a random
sample of normal glucose tolerant (NGT) (n = 821) and participants with type 2 diabetes
(T2D) (n = 861) recruited from the urban part of the Chennai Urban Rural Epidemiology
Study (CURES). A validated food frequency questionnaire (FFQ) was used for dietary
assessment and self-reported physical activity measures were collected. The threshold for
significance was set at P = 0.00023 based on Bonferroni correction for multiple testing [(0.05/
210 (3 SNPs x 14 outcomes x 5 lifestyle factors)]. After Bonferroni correction, there was a sig-
nificant interaction between the TCF7L2 rs12255372 SNP and fat intake (g/day) (Pinteraction =
0.0001) on high-density lipoprotein cholesterol (HDL-C), where the ‘T’ allele carriers in the
lowest tertile of total fat intake had higher HDL-C (P = 0.008) and those in the highest tertile
(P = 0.017) had lower HDL-C compared to the GG homozygotes. In a secondary analysis of
SNPs with the subtypes of fat, there was also a significant interaction between the SNP
rs12255372 and polyunsaturated fatty acids (PUFA, g/day) (Pinteraction <0.0001) on HDL-C,
where the minor allele carriers had higher HDL-C in the lowest PUFA tertile (P = 0.024) and
those in the highest PUFA tertile had lower HDL-C (P = 0.028) than GG homozygotes. In addi-
tion, a significant interaction was also seen between TCF7L2 SNP rs12255372 and fibre intake
(g/day) on HDL-C (Pinteraction<0.0001). None of the other interactions between the SNPs and
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lifestyle factors were statistically significant after correction for multiple testing. Our findings indi-
cate that the association between TCF7L2 SNP rs12255372 and HDL-C may be modified by die-
tary fat intake in this Asian Indian population.
Introduction
Genetic variants, unhealthy dietary intake, physical inactivity and their multiple interactions
are considered to be contributory factors to the development of obesity and type 2 diabetes
(T2D) [1–3]. After China, India has the highest number of people with T2D in the world and
according to the Indian Council of Medical Research–INdia DIABetes (ICMR–INDIAB)
study, T2D cases have reached 62.4 million and 77.2 million people are pre-diabetic [4]. Fur-
thermore, obesity and T2D are risk factors for non-communicable diseases (NCDs) such as
cardiovascular disease (CVD) and it is estimated that India will have the highest rate of CVD
mortality in the world [5]. Asian Indians have different biochemical characteristics from other
populations from birth, often referred to as the ‘Asian Indian Phenotype’ which consists of
increased visceral fat and waist circumference, hyperinsulinemia and insulin resistance [6].
The association between several genes and metabolic diseases has been identified by the
candidate gene approach and genome-wide scans; to date, besides the FTO (Fat mass and obe-
sity associated) gene, the strongest obesity risk loci known so far [1, 3, 7, 8], two commonly
studied candidates for obesity and T2D have been the Melanocortin 4 Receptor (MC4R) and
Transcription Factor 7-Like 2 (TCF7L2) genes. Strong association between the MC4R gene
and risk of obesity was identified by a genome-wide association (GWAS) study [9] whereas the
association between the Transcription Factor 7-Like 2 (TCF7L2) gene and risk of T2D was
identified by a genome wide linkage study [10]. MC4R is expressed in the hypothalamus within
the brain and therefore it is suggested that it contributes to body weight regulation by its effect
on food intake and energy homeostasis [11]. A strong association was identified between
MC4R rs17782313 genetic variant and risk of obesity in a European population [12] which was
then replicated in other populations [13–15], including Asian Indians [16]. The TCF7L2 gene
is involved in the Wnt signalling pathway where it affects the expression of pro-glucagon and
consequently blood glucose regulation [10]. In addition, the effect of pro-glucagon on Gluca-
gon-like peptide 1 (GLP-1) also influences blood glucose regulation with insulin [17].
Decreased insulin secretion and increased glucose production in the liver is suggested to be
the result of over expression of the TCF7L2 gene [18]. A couple of studies [19, 20] have shown
strong associations between the two TCF7L2 single nucleotide polymorphisms (SNPs)
(rs7903146, rs12255372) and risk of T2D among Asian Indians living in India, in addition to a
meta-analysis [17].
In recent years, several studies have examined whether the association between the genetic
variants of MC4R and TCF7L2 genes and cardio-metabolic traits is modified by lifestyle factors
such as diet and physical activity in various populations [21–25], however there are no studies
to date among Asian Indians [26]. Whilst most studies in European populations found no sig-
nificant interactions between the MC4R SNP rs17782313 and dietary factors on obesity traits
[11, 22, 23], a prospective cohort study reported significant interactions between the SNP and
fat and protein intake on body mass index (BMI) and risk of T2D [27]. Similarly some studies
identified significant interactions between TCF7L2 SNPs and fibre and fat intake on T2D[28–
30]; however there were discrepancies between the studies which could be due to differences
in sample size, study design, dietary assessment and genetic heterogeneity. The objectives of
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this paper were to determine whether the MC4R SNP rs17782313 and TCF7L2 SNPs
(rs7903146, rs12255372) were associated with cardio-metabolic traits and whether the associa-
tion was modified by diet and physical activity in a sample size of up to 1,682 adults from the
Chennai Urban Rural Epidemiology Study (CURES).
Materials and methods
Study participants
A random, unrelated sample of normal glucose tolerant (NGT) (n = 821) and T2D (n = 861)
participants were recruited from the urban part of the cross sectional Chennai Urban Rural
Epidemiology Study (CURES) which included 26,001 individuals in total as a representative
sample of Chennai city. Full details of the methodology have been explained previously [31].
Briefly 26,001 adult subjects (>20 years of age) were recruited in Phase 1 of CURES using a
systematic random sampling method covering the whole Chennai city. This included 1,529
‘self-reported’ diabetic subjects. In Phase 2, all self-reported or ‘known diabetic’ subjects were
invited to our centre for detailed studies of whom 1382 responded (response rate: 90.4%). In
Phase 3, every tenth subject from Phase 1, excluding those with self-reported diabetes, under-
went an oral glucose tolerance test (OGTT). Subjects who had fasting plasma glucose<5.6
mmol/l (100mg/dl) and 2 hr plasma glucose value 7.8 mmol/l (140mg/dl) were categorized as
having NGT [32]. Those who were confirmed by OGTT to have 2 hr plasma glucose value 11.1
mmol/l (200 mg/dl) were classed as ‘newly detected diabetic subjects’ (n = 222).For the present
study, the NGT subjects were selected from Phase 3 and subjects with T2D which included
‘known diabetic’ and ‘newly detected diabetic’ subjects were selected from Phase 2 and Phase 3
of the Chennai Urban Rural Epidemiology Study. The Madras Diabetes Research Foundation
Institutional Ethics Committee granted the ethical approval and informed consent was
obtained from the study participants.
Anthropometric and biochemical measurements
Weight, height and waist circumference were measured by standard methods. The BMI calcu-
lation was based on the body weight (kg) divided by the square of body height (m). Roche
Diagnostics (Mannheim) provided the equipments in order to be able to carry out the bio-
chemical analyses on a Hitachi-912 Auto Analyzer (Hitachi, Mannheim, Germany)(8). Fasting
plasma glucose, serum cholesterol, serum triglycerides (TG) and high-density lipoprotein cho-
lesterol were measured by glucose oxidase-peroxidase, cholesterol oxidase-phenol-4-amino-
antipyrene peroxidase, glycerol phosphatase oxidase-phenol-4-amino-antipyrene peroxidise
and polyethylene glycol-pretreated enzyme methods respectively(8). The Friedewald formula
was used to estimate low-density lipoprotein cholesterol concentrations [33]. Glycated haemo-
globin (HbA1c) and serum insulin were determined by high-performance liquid chromatogra-
phy (HPLC) on a Variant instrument (Bio-Rad, Hercules, CA, USA) and an enzyme-linked
immunosorbent assay (Dako, Glostrup, Denmark) respectively [8].
Assessment of dietary intake and physical activity
A validated, interviewer administered semi-quantitative food frequency questionnaire (FFQ)
[34] consisting of a list of 222 different foods was used in order to evaluate dietary intake for
the previous year including macronutrient and total energy intake. Frequencies (per day,
week, month, year, never) and portion sizes were estimated by the participants with the help of
visual aids of measurement equipments and food sizes. Daily average food and nutrient intake
was calculated by the EpiNu database system.
TCF7L2 polymorphism interacts with dietary fat intake on HDL cholesterol
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A validated self-report questionnaire was used to measure physical activity [5]. Individuals
were divided into the vigorously active group when they both exercised and engaged in
demanding work activities whereas within the moderately active group the participants either
exercised or carried out heavy physical work. The remainder of the study participants were
separated into the sedentary group.
SNP selection and genotyping
A strong association was identified between MC4R rs17782313 genetic variant and risk of obe-
sity in a European population [12] which was then replicated in other populations (13–15),
including Asian Indians [16]. Strong associations have also been found between TCF7L2 SNPs
(rs12255372 and rs7903146) and risk of T2D in a meta-analysis [17] in the Japanese population
[35] as well as in Asian Indians [19, 20]. Although the TCF7L2 SNPs (rs12255372 and rs7903
146) have showed significant linkage disequilibrium (r2 = 0.746), the rs7903146 variant has
been shown to have the strongest effect in Caucasian populations [36, 37]. Based on the previ-
ous studies, the above mentioned three SNPs were selected for the present study.
Phenol-chloroform method was used to extract DNA from whole blood. The methodology
for genotyping TCF7L2 rs12255372 (G/T) and rs7903146 (C/T) SNPs has been previously pub-
lished [20]. Direct sequencing by an ABI 310 genetic analyzer (Applied Biosystems, Foster
City, CA) helped to confirm the efficiency of the genotyping which was in 99% concordance
based on random duplicates of 20% of the samples [20].
MC4R rs17782313 (T/C) SNP: PCR volume (10 μl) consisted of 1X reaction buffer, 200
mmol of dNTP, 1.5 mmol of MgCl2, 1 U taq DNA polymerase and 100 ng of genomic DNA.
The concentrations for primers included 15 pmol of common primer, 15 pmol of allele 1
primer and 1 pmol of allele 2 primer, equal to a 15:1 ratio of short primers to long primer.
Cycles for PCR were carried out at 96˚C for 12 min, then 35 cycles at 94˚C for 30 sec, followed
by 30 sec at 57˚C, 30 sec at 72˚C and finally for 10 min at 72˚C. Electrophoresis was carried
out with a 3% agarose gel.
Inner primers
F: AAGTTTAAAGCAGGAGAGATTGTATACC (C allele 222bp)
R: GCTTTTCTTGTCATTTCCAGCA (T allele 149bp)
Outer primer
F: TTACTGATTTTAAGGGCATAAGCAA
R: TATCATGCTGAGACAGGTTCATAAA (321bp)
Statistical analyses
Statistical analyses were carried out by using SPSS software (version 21). BMI 25 kg/m2 was
categorised as obese and BMI< 25 kg/m2 as non-obese. Descriptive statistics for continuous
variables are shown as means and standard deviation (SD). Fasting serum insulin and triglyc-
eride values were log transformed to obtain normal distribution. Genotype frequencies
between cases and controls were compared by Chi Square test. The difference in the means of
continuous variables between the genotypes was analysed by independent sample t test. Based
on an additive model of analysis, dominant models were used for all 3 single nucleotide poly-
morphisms (SNPs) where the common homozygous allele was compared to the combined het-
erozygous and rare homozygous alleles due to the low allele frequency of rare homozygotes.
Association analyses between SNPs and continuous and categorical variables were carried out
by linear and logistic regression models, respectively, adjusting for age, gender with the addi-
tion of BMI, when T2D was the outcome, and, adjusting for T2D, when obesity was the out-
come. Linear and logistic regression models were also used for interaction analyses between
TCF7L2 polymorphism interacts with dietary fat intake on HDL cholesterol
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SNPs and dietary factors (continuous variables) / physical activity (categorical variable) on
continuous and categorical outcomes respectively, where the interaction terms were included
into the models and were adjusted for age, gender, BMI, T2D and total energy intake when
appropriate. Bonferroni correction for multiple testing was calculated by multiplying 3 SNPs
with 14 outcomes (T2D, obesity, BMI, waist circumference, fasting blood glucose, HbA1c, fast-
ing insulin, systolic and diastolic blood pressure, HDL, LDL, VLDL, TG and total cholesterol)
and 4 dietary factors (carbohydrate, protein, fat, fibre) and physical activity level. The P value
of 0.05 was then divided by 210 (3 SNPs x 14 outcomes x 5 lifestyle factors) which set the sig-
nificant p value for all results at P = 0.00023.
As a secondary analysis, given the significant SNP-fat intake interaction, individuals were
grouped into tertiles based on the fatty acid subtypes [monounsaturated (MUFA) and polyun-
saturated (PUFA) fatty acids] for testing the interaction between SNPs and these fatty acid sub-
types on lipids. In addition, PUFA was further stratified into ALA (alpha linolenic acid) and
LA (linoleic acid) for the interaction analysis.
Given that there are no previously reported effect sizes for the gene-diet interaction, we
were unable to perform a prospective power calculation. However, based on the most signifi-
cant interaction observed in the present study, we performed retrospective power calculations
using QUANTO software, Version 1.2.4 (May 2009). We performed power calculations in the
form of least detectable effects based on the assumption of significance levels and powers of 5
and 80%, respectively. At 80% power, the minimum detectable effects ranged from beta 0.02
mg/dl (HDL-C) for a SNP with MAF of 5% to beta 1.0 mg/dl for a SNP with MAF 50% in the
case-control analysis. For the TCF7L2 SNP–fat intake interaction on HDL-C (most significant
interaction), the beta was 0.067, which is within the range of effect sizes for which the power
was calculated.
Results
Phenotypic associations
Based on the clinical and biochemical characteristics of the individuals from the CURES
study as illustrated in Table 1, individuals with T2D were older (P<0.0001), had higher
BMI (P<0.0001), waist circumference (P<0.0001), fasting plasma glucose (P<0.0001),
HbA1c (P<0.0001), fasting plasma insulin (P<0.0001), systolic and diastolic blood pressure
(P<0.0001), low density and very low density lipoproteins (P<0.0001), total cholesterol
(P<0.0001), TG (P<0.0001) and lower high density lipoprotein (P = 0.001) than NGT
individuals.
Genetic associations
The minor allele (‘T’) of SNPs (rs12255372 and rs7903146) of TCF7L2 gene showed significant
susceptibility to T2D; however, in the present study after correction for multiple testing only
the association between SNP rs7903146 and T2D remained statistically significant (P = 0.0001)
(S1 Table).After Bonferroni correction, statistically significant association between the ‘C’
allele of theMC4R SNP rs17782313 and T2D was also observed (P = 0.00022) (S2 Table). None
of the associations between the three SNPs and continuous variables remained significant after
correction for multiple testing (P>0.00023) (S1 and S2 Tables).
TCF7L2 –dietary fat intake interactions on HDL-C
Individuals were grouped into tertiles based on their fat and subtypes of fat intake (g/day). The
means for fat intake in the 1st tertile: 41 g/d; 2nd tertile: 62 g/d; 3rd tertile: 95 g/d. Means for
TCF7L2 polymorphism interacts with dietary fat intake on HDL cholesterol
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PUFA intake in the 1st tertile: 9g/d; 2nd tertile: 17 g/d; 3rd tertile: 29 g/d. Means for MUFA
intake in the 1st tertile: 12 g/d; 2nd tertile: 18 g/d; 3rd tertile: 29 g/d. Means for ALA intake in
the 1st tertile: 0.38 g/d; 2nd tertile: 0.58 g/d; 3rd tertile: 0.89 g/d. Means for LA intake in the 1st
tertile: 8 g/d; 2nd tertile: 17 g/d; 3rd tertile: 29 g/d.
The interaction between the TCF7L2 SNP rs12255372 and fat intake (g/day) on HDL-C was
statistically significant after correction for multiple testing (Pinteraction = 0.0001). The ‘T’ allele
carriers of the TCF7L2 SNP rs12255372 had 2.26 mg/dl higher HDL-C level in the lowest tertile
of fat intake (mean: 41 g/day) than the ‘GG’ homozygotes (P = 0.008) and in the highest tertile
of fat intake (mean: 95 g/day), HDL-C was 1.87 mg/dl lower in the risk ‘T’ allele carriers in
comparison to the ‘GG’ homozygotes (p = 0.017) (Fig 1).
Stratification to fat subgroups showed significant interactions between the SNP rs12255372
and PUFA (g/day) on HDL-C (Pinteraction<0.0001), where the ‘T’ allele carriers had 1.96 mg/dl
higher HDL-C (P = 0.024) in the low PUFA tertile (mean: 9 g/day) in comparison to the ‘GG’
homozygotes and in the 3rd tertile (mean: 29 g/day), the HDL-C level of the ‘T’ allele carriers
was 1.64 mg/dl lower than the ‘GG’ homozygotes (P = 0.028) (Fig 1). A similar interaction was
also found between the SNP rs12255372 and MUFA (g/day) on HDL-C (Pinteraction = 0.0003),
Table 1. Anthropometric and biochemical characteristics of T2D and NGT participants.
NGT T2D P value*
N 821 861
(men/women) (345/476) (398/463) 0.08
Age (yrs) 41.31±11.73 50.57±10.49 <0.0001
BMI (kg/m2) 23.66±4.69 25.34±4.30 <0.0001
WC (cm) 83.55±11.66 90.60±9.84 <0.0001
FPG (mg/dl) 84.82±8.36 161.73±69.13 <0.0001
HbA1c (%) 5.58±0.48 8.78±2.36 <0.0001
INS (μIU/ml) 8.41±5.81 11.78±7.69 <0.0001
Log INS (μIU/ml) 6.85±1.87 9.68±1.90 <0.0001
Systolic BP (mmHg) 117.72±18.05 129.16±21.65 <0.0001
Diastolic BP (mmHg) 74.06±11.32 76.76±11.85 <0.0001
HDL (mg/dl) 43.36±9.91 41.71±9.50 0.001
LDL (mg/dl) 113.13±30.55 124.49±35.38 <0.0001
VLDL (mg/dl) 23.95±14.30 35.96±27.37 <0.0001
TC (mg/dl) 180.02±36.02 199.51±42.40 <0.0001
TG (mg/dl) 120.18±71.46 180.31±137.12 <0.0001
Log TG (mg/dl) 105.68±1.62 152.75±1.71 <0.0001
Total energy (Kcal/day) 2622.43±702.77 2468±893.75 <0.0001
Total Carbohydrate (g) 419.69±112.33 399.96±147.98 0.002
Fat (g) 68.57±24.29 64.25±27.31 0.001
Total PUFA (g) 18.22±9.09 18.75±10.04 0.25
Total MUFA (g) 20.51±7.77 18.79±8.37 <0.0001
Protein (g) 73.82±20.97 69.93±24.56 0.001
Dietary fibre (g) 31.41±9.83 31.66±12.19 0.64
Data presented as Mean±SD.
*P values are showing the differences in mean values between NGT and T2D participants.
Abbreviations: NGT, normal glucose tolerance; BMI, Body mass index; WC, waist circumference; HbA1C, glycated haemoglobin; FPG, Fasting plasma
glucose; INS, Fasting plasma insulin; HDL, high density lipoprotein; LDL, low density lipoprotein; VLDL, very low density lipoprotein; TC, Total Cholesterol;
TG, triglycerides.
https://doi.org/10.1371/journal.pone.0188382.t001
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where the ‘T’ allele carriers had 1.77 (mg/dl) higher HDL-C in the lowest MUFA tertile (mean:
12 g/day) (P = 0.03) and had 1.61 (mg/dl) higher HDL-C in the 2nd tertile (mean: 18 g/day)
(P = 0.045) than the ‘GG’ carriers, however in the highest MUFA tertile (mean: 29 g/day) the
‘T’ allele carriers had 1.59 (mg/dl) decreased HDL-C (P = 0.041) than individuals with the
‘GG’ genotype.
PUFA was further stratified to linoleic acid (LA) and alpha linolenic acid (ALA) to investi-
gate whether omega-3 and omega-6 fatty acids modified the association between the TCF7L2
SNP rs12255372 and HDL-C. Significant interaction was found between the SNP and ALA
on HDL-C (Pinteraction = 0.012), where the ‘T’ allele carriers had 2.42 (mg/dl) higher HDL-C
than the ‘GG’ homozygotes (P = 0.004) in the lowest tertile (mean: 0.38 g/day) (Fig 1).A
similar interaction was also found between the SNP rs12255372 and LA (g/day) on HDL-C
(Pinteraction<0.0001). S1 Table shows the interactions of TCF7L2 SNP rs12255372 with fat,
PUFA and ALA intakes on HDL-C under an additive and dominant model.
Additional gene-diet interactions
In addition to the main significant findings, there was a significant interaction between TCF7L2
SNP rs12255372 and fibre intake (g/day) on HDL-C (Pinteraction< 0.0001), where in the lowest
tertile (mean: 20 g/day) individuals carrying the ‘T’ allele had 1.95 (mg/dl) higher HDL-C
(P = 0.02), in the 2nd tertile (mean: 30 g/day), the ‘T’ allele carriers had 2.39 (mg/dl) higher
HDL-C (P = 0.003) and in the highest tertile (mean: 44 g/day), the HDL-C level of the ‘T’ allele
carriers was 2.37 mg/dl lower in comparison to the ‘GG’ homozygotes (P = 0.002). There were
several other interactions which did not reach statistical significance after correction for multi-
ple testing and these interactions are shown in the Table 2 and S2 and S3 Tables).
Gene-physical activity interactions on cardio-metabolic traits
No statistically significant interactions were observed after correction for multiple testing between
the three SNPs and physical activity on obesity- and T2D- related traits (Pinteraction>0.0002).
Fig 1. Interaction of the TCF7L2 gene polymorphism (rs12255372) with fat (g) intake, PUFA intake and
Alpha Linolenic Acid (g) intake on HDL-C. Individuals carrying the ‘XT’ genotype had 2.26 mg/dl higher
HDL-C in the lowest fat tertile (P = 0.008), while those in the highest tertile had 1.87 mg/dl lower HDL-C
(P = 0.017) than those who carry the ‘GG’ allele. Carriers of the ‘XT’ genotype had 1.96 mg/dl higher HDL-C in
the 1st tertile of PUFA intake (g) (P = 0.024), while those in the 3rd tertile had 1.64 mg/dl lower HDL-C in
comparison to the carriers of the ‘GG’ genotype (P = 0.028). In the 1st tertile of Alpha Linolenic acid intake (g),
individuals with the ‘XT’ genotype had 2.42 mg/dl higher HDL-C than the ‘GG’ homozygotes (P = 0.004).
https://doi.org/10.1371/journal.pone.0188382.g001
TCF7L2 polymorphism interacts with dietary fat intake on HDL cholesterol
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Interactions observed between TCF7L2SNP rs7903146 and physical activity on VLDL (Pinteraction =
0.012) and TG (Pinteraction = 0.014), where the risk ‘T’ allele carriers had higher TG and VLDL levels,
did not reach statistical significance after correction for multiple testing (S4 Table).
Discussion
This is the first study to investigate interactions between TCF7L2 and MC4R SNPs and lifestyle
factors on cardio-metabolic traits among Asian Indians. The main findings suggest that total
fat and PUFA intakes may modify the association between the TCF7L2 SNP rs12255372 and
HDL-C. In the lowest total fat and PUFA tertiles, participants carrying the ‘XT’ genotype (GT
+TT) had significantly higher HDL-C, whereas in the highest tertile participants carrying the
‘XT’ genotype had lower HDL-C, as compared to those with the GG genotype. This finding is
of public health significance given that Asian Indians tend to have low HDL-C which puts
them at markedly increased risk for CVD [38, 39].
The fat intake consists of invisible, hidden and visible fat (vegetable oils, ghee, butter) in
India where in the urban areas the minimum average daily intake of visible fat is approxi-
mately 22–45 g/day [40]. The recommended omega 3 PUFA intake is 0.1 gram/day, however
the median of combined intake of LA and ALA is 13 g/day and the recommended ratio
between LA and ALA is 5:1 to 10:1 [40]. In comparison, the results of our study suggest that
total fat intake below 53 g/day, PUFA intake below 13 g/day, and ALA intake below 0.49 g/day
may help maintain high levels of HDL-C in the ‘T’ allele carriers of the TCF7L2 SNP rs1225
5372. The findings that MUFA intake above 22 g/day reduces HDL-C and only ALA intake
below 0.5 g/day maintains high HDL-C level in risk carriers are unexpected results; however,
the effect of polygenic traits cannot be ruled out.
HDL-C is generally considered to be protective against CVD due to its role in the reverse
cholesterol transport; however, the recent Mendelian randomization (MR) studies [41, 42]
have failed to show a causal effect of low HDL-C on cardiovascular disease risk. But, none of
these MR studies have taken dietary factors into account. Furthermore, fatty acids have shown
to have different modulating effect on HDL-C for which the mechanism is not fully under-
stood [43]. On the other hand, it is argued that the total fat intake is more influential on post-
prandial lipoprotein abnormalities, which is a characteristic of T2D, than the type of fatty
acids [44]. However, studies have also shown that different fatty acids can have differential
effects on postprandial TG [45–47]. In our study, we found that those in the lowest fat intake
Table 2. Interactions of TCF7L2 SNPs rs12255372 and rs7903146 with carbohydrate, fibre and protein intake on HDL-C, fasting blood glucose and
diastolic blood pressure.
rs12255372 SNP*Carbohydrate (g) SNP*Fibre (g) SNP*Protein (g) SNP*Fat (g)
β ± SE** (P for interaction on FPG) 0.039 ± 0.019 (0.041) 0.437 ± 0.222 (0.049) 0.132 ± 0.108 (0.222) 0.119 ± 0.095 (0.210)
β ± SE** (P for interaction on HDL-C) 0.009 ± 0.003 (0.007) 0.168 ± 0.041 (<0.0001) 0.072 ± 0.020 (0.0003) 0.067 ± 0.017 (0.00017)
β ± SE** (P for interaction on DBP) -0.003 ± 0.004 (0.551) -0.107 ± 0.050 (0.033) -0.028 ± 0.024 (0.251) -0.032 ± 0.021 (0.130)
rs7903146 SNP*Carbohydrate (g) SNP*Fibre (g) SNP*Protein (g) SNP*Fat (g)
β ± SE** (P¥ for interaction on T2D) 0.002 ± 0.001 (0.011) 0.014 ± 0.010 (0.180) 0.011 ± 0.005 (0.024) 0.008 ± 0.004 (0.071)
β ± SE** (P for interaction on HDL-C) 0.006 ± 0.003 (0.057) 0.128 ± 0.040 (0.002) 0.050 ± 0.020 (0.010) 0.052 ± 0.017 (0.003)
*Interaction term
**P values are adjusted for age, gender, BMI, T2D and Total energy intake.
¥ P values are adjusted for age, gender, BMI and Total energy intake.
Abbreviations: SNP, Single nucleotide polymorphism; HDL-C, High density lipoprotein cholesterol; FPG, Fasting plasma glucose; DBP, Diastolic blood
pressure.
https://doi.org/10.1371/journal.pone.0188382.t002
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subgroups had higher HDL-C while those in the highest tertile groups had lower HDL-C
among the risk allele carriers. A previous intervention study in the US population [30] also
found significant interaction between SNP rs12255372 and fat intake where positive changes
in body composition were observed in the ‘T’ risk allele carriers only on the low-fat diet (20%
from total energy). Other studies only reported significant interactions between SNP
rs7903146 and high saturated fat intake on increased metabolic syndrome risk [29] and high
(n-6) PUFA intake (6.62% of energy intake) on increased VLDL and TG [24] among the risk
‘T’ allele carriers.
High omega 6 to omega 3 ratio has been shown to increase HDL in mice [43], whereas the
results from this study in humans contradict those findings. It has been shown in cell and ani-
mal studies that high omega 6 PUFA intake is pro-inflammatory leading to an increased risk
for CVD and diabetes [48] and in the present study reduced HDL was observed in the minor
allele carriers in response to high intake of omega 6 PUFA (>21.6 g/d). According to our find-
ings, a low omega 6 (<12.8 g/d) and a low ALA intake (<0.5 g/d) may help maintain HDL
above 44 (mg/dl) in the risk allele carriers.
Though there was no significant difference in mean HDL levels in the different tertiles of
total fat and PUFA intakes in the study participants (data not shown), in the presence of
TCF7L2 rs12255372 genotype, a clear interaction between the genotype and fat/ PUFA intake
on HDL-C was observed. While the carriers of ‘XT’ genotype had increased HDL-C in the
presence of a low fat/ low PUFA diet, there was a decrease in HDL-C levels in the carriers of
‘XT’ genotype in the presence of a high fat / high PUFA diet. It is to be noted that among those
who carry the GG genotype, irrespective of the dietary fat/PUFA intake, there is no effect on
HDL-C levels.
Another interesting interaction was the one between TCF7L2 SNP rs12255372 and fibre
intake on HDL-C. The results suggest that low and medium fibre intake (means: 20, 30 g/day),
respectively, increase HDL-C whereas high fibre intake (mean: 44 g/day) may reduce HDL-C
among risk allele carriers of the TCF7L2 SNP rs12255372. The average fibre intake in India is
30–40 g/day [40] which is consistent with the mean intake in the medium and high tertiles and
also higher compared to the mean fibre intake in the UK (~18g/day) and the US (~16g/day). A
previous study investigated interaction between SNP rs7903146 and fibre intake on T2D risk
[28],where the minor allele carriers had increased T2D risk with higher fibre intake (mean
intake: 13.1 ± 2.2 g/4,184 kJ). High fibre intake is generally recommended to improve glycemic
control in T2D individuals [49] and to reduce total and LDL-C in order to reduce CVD risk. A
meta-analysis of data from clinical studies (n = 2,990) [50] indicated that high fibre diets (20–
30 g/day) reduced HDL-C. Similarly, another meta-analysis of data from 24 clinical studies
also suggested that medium and high carbohydrate, high fibre (20 g/day) diets also decreased
HDL by 4% [51].However, it was argued, that the decrease in LDL-C and TG values would
reduce CVD risk by 16.4% which would outweigh the increased risk of CVD by 11.9% due to
decreased HDL [51]. But it is of note that these meta-analyses did not consider the genetic
component and, furthermore, we also observed gene-diet interaction on other lipid outcomes
such as VLDL and TG, which did not remain significant after correction for multiple testing.
The risk of coronary artery disease is increased in individuals with circulating HDL-C con-
centration of<40 mg/dl [52]. In our study, within the high fibre intake tertile (35g/day), the
mean HDL-C level of the minor risk allele carriers was 39.46 mg/dL in comparison to 42.27
mg/dl of the ‘GG’ carriers of the TCF7L2 SNP rs12255372. The results of our study suggest that
high fibre intake (35–102 g/day) may help maintain HDL-C level above 40 mg/dl whereas
below 35 g/day may lower HDL-C in the ‘GG’ genotype carriers of SNP rs12255372. Mecha-
nisms on how low/high fibre intake decreases/increases HDL-C are not well understood and
more research is needed to clarify the effects of dietary fibre on HDL-C metabolism [52, 53].
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No studies, to date, have investigated interactions between the TCF7L2 SNPs
(rs12255372 and rs7903146) and MC4R SNP rs17782313 and physical activity on cardio-
metabolic traits in Asian Indians. Despite the fact that the majority of people are physically
inactive in India [54], no significant interactions were found after correction for multiple
testing between the three polymorphisms and physical activity on cardio-metabolic traits,
which could be due to a small sample size and measurement bias associated with self-
reported physical activity questionnaire. However, our finding is in support of the previ-
ous study in a Spanish population [21] with a much larger sample size (n = 7,052) which
also did not find a significant interaction between MC4R SNP rs17782313 and physical
activity on obesity traits. Though the inclusion of a representative sample of Chennai for
analysis and the use of a comprehensive, validated, interviewer administered semi-quanti-
tative FFQ for dietary assessment could be considered the strengths of this study, there are
some underlying limitations. The data used to calculate the measures of dietary intake and
physical activity came from self-report and hence, measurement bias associated with self-
reported questionnaire cannot be ruled out. Given that obesity and diabetes are multifac-
torial traits, several genetic and lifestyle factors are likely to contribute to the disease.
While 97 loci have been shown to be associated with body weight [55], the present study
examined only three common variants, given their consistent associations with obesity
and diabetes, respectively, in Europeans and Asian Indians. The cross sectional study
design gives only a snapshot of the prevalence and cause—effect cannot be established due
to lack of follow up which is another limitation of this study. However, several outcomes
and risk factors were assessed and there was no loss to follow up.
In conclusion, this study has found significant interactions between the TCF7L2 SNP
rs12255372 and dietary factors on HDL-C in this Asian Indian population. The results of
this study indicate that high total fat and PUFA intakes may be associated with lower
HDL-C whereas low intake is associated with higher HDL among the risk allele carriers.
More research is required to better understand the interactions between the TCF7L2 gene
variant and lifestyle factors on cardio-metabolic traits. Exact mechanisms identifying the
effect of different fatty acids on HDL-C and whether/how high fat- and PUFA- intake may
reduce HDL-C should also be established before public health recommendations and per-
sonalised nutrition advice can be developed for this Asian Indian population in order to
reduce the burden of cardiometabolic diseases.
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